We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Envela
ELA
$536M
| $2M | ﹤0.01% |
+120,238
| New | +$1.65M |
|
2252
Vaalco Energy
EGY
$594M
| $2M | ﹤0.01% |
315,298
-21,319
| -6% | -$107K |
|
2253
Rocky Brands
RCKY
$304M
| $2M | ﹤0.01% |
51,573
+7,069
| +16% | +$257K |
|
2254
Orthofix Medical
OFIX
$455M
| $1.99M | ﹤0.01% |
173,734
-158,308
| -48% | -$2.09M |
|
2255
Monte Rosa Therapeutics
GLUE
$1.92B
| $1.99M | ﹤0.01% |
120,872
-164,987
| -58% | -$3.16M |
|
2256
Surgery Partners
SGRY
$2.06B
| $1.99M | ﹤0.01% |
166,797
+1,050
| +0.6% | +$15.1K |
|
2257
Certara
CERT
$1.17B
| $1.98M | ﹤0.01% |
347,140
-453,488
| -57% | -$3.46M |
|
2258
LGI Homes
LGIH
$1.4B
| $1.98M | ﹤0.01% |
49,987
+356
| +0.7% | +$17.4K |
|
2259
Esquire Financial Holdings
ESQ
$1.04B
| $1.96M | ﹤0.01% |
18,267
-256
| -1% | -$27.4K |
|
|
ALM
2260
Almonty Industries
ALM
$3.79B
| $1.96M | ﹤0.01% |
135,199
+18,176
| +16% | +$260K |
|
2261
Tyra Biosciences
TYRA
$1.82B
| $1.95M | ﹤0.01% |
50,840
+3,491
| +7% | +$113K |
|
|
AUGO
2262
Aura Minerals Inc
AUGO
$4.58B
| $1.95M | ﹤0.01% |
23,852
| – | – |
|
2263
Sturm, Ruger & Co
RGR
$610M
| $1.94M | ﹤0.01% |
48,398
-1,241
| -3% | -$47.1K |
|
2264
Oric Pharmaceuticals
ORIC
$1.25B
| $1.94M | ﹤0.01% |
153,022
+8,619
| +6% | +$97.8K |
|
2265
Enovix
ENVX
$862M
| $1.93M | ﹤0.01% |
372,097
+26,900
| +8% | +$168K |
|
2266
CNA Financial
CNA
$14.5B
| $1.92M | ﹤0.01% |
41,848
+3,641
| +10% | +$172K |
|
2267
Stagwell
STGW
$1.84B
| $1.92M | ﹤0.01% |
305,424
+116,706
| +62% | +$653K |
|
2268
Cracker Barrel
CBRL
$1.2B
| $1.92M | ﹤0.01% |
68,219
+18,685
| +38% | +$569K |
|
2269
Southside Bancshares
SBSI
$1.02B
| $1.92M | ﹤0.01% |
61,665
+419
| +0.7% | +$13.3K |
|
|
TRST
2270
Trustco Bank Corp NY
TRST
$977M
| $1.9M | ﹤0.01% |
43,300
-1,949
| -4% | -$85.3K |
|
2271
Capital Bancorp
CBNK
$588M
| $1.89M | ﹤0.01% |
63,648
-3,326
| -5% | -$99.6K |
|
|
BDN
2272
Brandywine Realty Trust
BDN
$551M
| $1.89M | ﹤0.01% |
698,333
+328,129
| +89% | +$982K |
|
|
MAZE
2273
Maze Therapeutics
MAZE
$1.53B
| $1.89M | ﹤0.01% |
63,360
+6,102
| +11% | +$269K |
|
|
PDM
2274
Piedmont Realty Trust
PDM
$1.22B
| $1.89M | ﹤0.01% |
287,744
+1,991
| +0.7% | +$15.5K |
|
2275
Oxford Industries
OXM
$577M
| $1.89M | ﹤0.01% |
49,067
+159
| +0.3% | +$6K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.